Author:
Posner M.R.,Norris C.M.,Wirth L.J.,Shin D.M.,Cullen K.J.,Winquist E.W.,Blajman C.R.,Mickiewicz E.A.,Frenette G.P.,Plinar L.F.,Cohen R.B.,Steinbrenner L.M.,Freue J.M.,Gorbunova V.A.,Tjulandin S.A.,Raez L.E.,Adkins D.R.,Tishler R.B.,Roessner M.R.,Haddad R.I.
Reference19 articles.
1. Cancer statistics;Jemal;CA Cancer J Clin,2008
2. Phase III study on larynx preservation comparing induction chemotherapy and radiotherapy versus alternating chemoradiotherapy in resectable hypopharynx and larynx cancers. EORTC protocol 24954–22950;Lefebvre;J Clin Oncol,2007
3. Randomized phase III trial comparing induction chemotherapy using cisplatin, fluorouracil with or without docetaxel for organ preservation in hypopharynx and larynx cancer. Preliminary results of GORTEC 2000–01;Calais;J Clin Oncol,2006
4. Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database;Carvalho;Int J Cancer,2005
5. Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience;Brockstein;Ann Oncol,2004
Cited by
129 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献